Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
How appropriate then, that someone who typically plays the ‘village idiot’ comes out with the truth.
Whether the ‘false narrative’ is finally crumbling or not, is not directly related to analyzing price action.
It does, however, provide the backdrop.
The ‘Big Reveal’
The last update in biotech had this to say (emphasis added):
“If this is the big reversal and biotech is the downside leader, unfortunately, that could mean a planned ‘reveal’ by the mainstream media.“
What wasn’t known, was just exactly how the truth would come out. Now, we know.
All of which, brings us to the topic at hand: Biotech SPBIO.
It turns out, SPBIO, is trading most consistently, on a three-day pattern.
Biotech SPBIO, 3-Day
In Wyckoff terms, the market itself defines what timeframes and what support/resistance levels are important.
Next up, we’re going to invert the chart to mimic the price action observed on the leveraged inverse fund LABD.
Biotech SPBIO, 3-Day, Inverted
And now, the characteristics of this sector the market itself, has revealed.
At this juncture, SPBIO, trades in a sequence of 3-Days after which, if there’s a directional move, continues on for nine consecutive bars.
After nine-bars, price action typically enters a correction for an undetermined amount of time.
After the correction’s compete the market has (in the past) continued on a directional move for another nine-bars.
Then & Now
We’re currently in a directional move that’s five ‘3-Day Bars’ in thus far.
If the market adheres to its prior behavior(s), we have at least four more ‘three-days’ to go (not advice, not a recommendation).
Note, the current reversal was identified to the day, with this update:
“However, today’s action is consistent with resolution of the five-months of congestion (not advice, not a recommendation).”
The fact the congestion period for SPBIO has taken so long to (apparently) resolve itself, has produced the potential for price action to go farther, last longer than anyone would normally expect.
That move if it happens, connects well with the introduction at the top of this post; a large part of the public has been informed in no uncertain terms, it was all a lie.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
With today’s heavy downward action, as we head into the close, any number of scenarios could play out.
Work has already been done on INTC, KMX, MRNA, Biotech Leveraged Inverse LABD, and others.
With such a decisive push lower, there could be some kind of short covering late in the session.
For example, as of this post 2:15 p.m. EST, KMX (detailed below) appears to be coming off the day’s lows.
CarMax Weakness
The daily chart has KMX, right a the bottom of a trading channel.
Price action may continue to rebound from this area heading into the close or not.
If there’s a rebound, naturally Put options will begin to decay in value … a desired outcome if one is looking to enter short (at the cheapest price possible).
The bottom of the channel line could be all there is for this week or we could be heading to much lower levels.
It’s up to the trader/speculator to decide (not advice, not a recommendation)
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
With that understood, we’ll present three potential scenarios for Moderna (MRNA) price action for the upcoming days, or week(s).
When we last left our chief cook and spike-protein injector, price action was in a downtrend but also in Wyckoff spring position; indicating at least a chance for upside.
As with the CarMax (KMX) analysis, still playing out with Scenario No. 2, and/or No. 3, at this link as the forecasted price action, we’ll show potential Scenario No. 1 – No. 3, for MRNA, below.
Moderna MRNA, Daily, Forecasted Action
Scenario No. 1
Upside wedge breakout
Scenario No. 2
Downside wedge breakout with no test
And now, the most probable, ‘If there’s a downside breakout.
From a short-dated options standpoint, Scenario No. 3, is the most desirable (not advice, not a recommendation).
If there’s a downside breakout with no test, there’s always the possibility at some point, there will be a test, which in turn completely wipes out any potential gain in the (put) trade; time would run out and the option expires.
Re-Visiting, Elder
Recall, in the example that Dr. Elder gave, he bought OEX Put Options at 3/8-ths, back in the day when the markets traded in fractions.
Three-eighths is 0.375, which gives a target value on which option to select (not advice, not a recommendation).
To get to that small of a fraction, the option’s either way out of the money, short on time, or both.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
With a potential right-side trend (and channel) contact confirmed; shown below at – 86% annualized, odds are now favorable for a Put strategy.
In addition to the technical factors discussed, listed at the bottom of this post are no fewer than 22-links to the current fundamental state of biotech and their ‘handiwork’.
The weekly chart of MRNA, has a Wyckoff Up-Thrust and a test, confirmed by the downside pivot.
Moderna MRNA, Weekly
Notice the reversal action took place at a very weak Fibonacci 23.6% retrace.
The two blue lines on the daily chart (below) are exactly parallel.
The grey lines are parallel to the blue lines and intended to show MRNA, exhibits a repeating (downtrend) pattern.
Moderna MRNA, Daily
The expanded version on the daily has support being penetrated (horizontal blue line) and then ‘spring’ action last Friday as a result.
Of course, it’s ‘what happens next’, that’s the question.
In a prefect scenario, price action would thrust lower for a day or several days and then come back up to test the underside of resistance.
Elder Option Strategy
This strategy is taken from Elder’s book ‘Come Into My Trading Room’, and seeks to use as short-dated options as possible.
Doing so, requires the discipline to wait sufficient amount of time for price action to get into position and for option time value to bleed-off.
Potential Upside
Since we’re already in spring position and price action moved off the lows on Friday, MRNA could continue the upside right back to, or past the downtrend line.
However, with massive (undeniable) fundamentals building buy the day, and MRNA being mentioned specifically in at least one link below, probabilities favor the downside.
Supporting Links For The Bearish Stance
Florida Surgeon General Warns Life-Threatening VAERS Reports Up 4,400 Percent Since COVID-19 Vaccine Rollout
US Says Government, Not Moderna, Should Face COVID-19 Vaccine Lawsuit
New Medical Codes For COVID Vaccination Status Raise Concerns Among Experts
Watch: Rand Paul Grills School Of Nursing Head On Student COVID Vaccine Mandate
US Navy Lifts COVID Vaccine Mandate For Sailor Deployment
Mainstream Media Continues To Push False ‘COVID Heart’ Narrative To Explain Excess Deaths
NFL Players’ Association Urged To Screen for Heart Issues Over Vaccine Side Effects
WHO Suddenly Shelves Plans For Second Phase Investigation Into Origins Of COVID-19: Report
Watch: CDC Director Suggests It Will Never Change Child-Masking Policy
Rand Paul Introduces Bill To Halt Funding For Hospitals Denying Care To The Unvaxxed
Welfare State Weakens… 30 Million Americans Are About To Lose ‘COVID’ Food Stamp Handouts
IMF Says World Needs To Prepare For The “Unthinkable” After COVID, War In Ukraine
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Intel’s a dog … and has been for a very long time.
How do we know that? The price action itself, tells us.
Looking at the weekly chart of INTC, overlaid with the SOXX (thin black line), it’s clear, things literally went south for INTC, right around April, of 2021.
Intel reversed while the sector, the SOXX continued higher.
It’s what happened next, that’s important.
Intel INTC, With SOXX, Weekly
Note how the SOXX has rebounded since mid-October last year while Intel has remained flat.
Even with all the market manipulation to keep the major indices trending higher, having the public thinking ‘the consumer is strong’, INTC has languished.
This lack of upward price action in a rising market, indicates significant weakness.
Has Intel reached a bottom? This is the ‘dip’, isn’t it?
As always, anything can happen and INTC, could launch higher from here. However, it’s not likely.
It’s a juggernaut and at the moment, heading lower.
All of which brings us to the set-up: Options trade to the short side.
Intel INTC, Daily
For a viable Put trade, at least two criteria need to be met (with downtrend already established) and those are: Option time bleed, and what’s called ‘price instability’ or a ‘test’.
The daily close of INTC, shows a prior set-up (‘Test’) and now, at the far right of the chart, forecasted action.
A possible time for the ‘test’ if it occurs would be this coming Wednesday as that makes it ‘Day 13’ from the high on February 3rd.
That day would also coincide with the Fed minutes being released at 2:00 p.m., EST.
Note: When Fibonacci time counts are involved, it was determined years ago (by my firm), when the U.S. market is closed for a holiday and the rest of the world markets are open, it can (and sometimes does) count as a Fibonacci trading day.
Therefore, with world markets open this Monday, and the U.S. closed, it may still count as a Fibonacci trading day.
That in turn, could make this Tuesday ‘Day 13’ (not advice, not a recommendation).
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
If there was any remaining hope for the economy, the next leg lower in bonds (with rates higher) should just about take care of it.
Of course, if one knows what’s likely to happen, then preparations can be made.
The breakdown in bonds is already underway and this morning’s pre-market action (as of 9:08 a.m., EST) is more of the same … down.
The daily chart of bond proxy TLT, shows the wedge and measured move. With that said, there’s no guarantee of bonds heading lower, just probabilities.
Also, if bonds go lower there’s nothing that says they can’t just keep going … with rates ever higher.
Bonds TLT, Daily
Of course, one does not have to sit idly by and watch their account(s) be decimated with persistent down moves.
Leveraged inverse bond fund TBT, has been around a long time; it’s a viable tool to either hedge positions or trade outright (not advice, not a recommendation).
Leveraged TLT, Inverse: TBT, Daily
Within the past two weeks, TBT, is up over +11%, which is quite respectable for a bond fund.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Newmont (NEM) price action’s working its way lower to a ‘free-fall’ area; shown below.
Depending on behavior if or when it gets to this area, there could be an acceptable set-up to execute an ‘Elder-type’ Put option (not advice, not a recommendation).
That Put strategy has already been discussed but for those who may be new, it’s basically a short-expiration, out-of-the-money Put for maximum (potential) gain.
A completely counter-intuitive approach to the standard method of long-dated entries, then ‘wait’ while the value burns down to nothing.
Newmont Mining NEM, Daily
The compressed chart has the big picture; Newmont’s all-time highs were reversed on April 18th, 2022.
It’s currently in the process of finding its long-term bottom which is possibly far away from current levels.
The next chart gets close in on the potential set-up.
If price action follows its current down-trend, NEM may reach the potential free-fall area late next week.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
